Nvidia Has 81% of Its $304 Million Stock Portfolio Invested in 3 Groundbreaking AI Stocks

Full Article

Nvidia, a leading semiconductor company, has invested 81% of its $304 million stock portfolio in three significant AI companies. This strategic move highlights Nvidia's commitment to enhancing its position in the rapidly evolving AI landscape. The investments include Arm Holdings, Applied Digital, and Recursion Pharmaceutical, each playing a unique role in the AI ecosystem.

Arm Holdings, with a substantial investment of $135.8 million, is pivotal for chip technology, while Applied Digital focuses on building AI-specific data centers. Recursion Pharmaceutical leverages AI for innovative drug discovery, showcasing the diverse applications of AI across industries. These investments not only bolster Nvidia's portfolio but also reflect the growing importance of AI in various sectors.

• Nvidia invests 81% of its portfolio in three AI companies.

• Arm Holdings' shares have more than doubled since its IPO.

Key AI Terms Mentioned in this Article

Artificial Intelligence (AI)

AI refers to the simulation of human intelligence in machines, enabling them to perform tasks that typically require human cognition.

Data Centers

Data centers are facilities used to house computer systems and associated components, crucial for AI applications requiring high-performance computing.

Machine Learning

Machine learning is a subset of AI that enables systems to learn from data and improve their performance over time without explicit programming.

Companies Mentioned in this Article

Nvidia

Nvidia develops high-end GPUs that are essential for powering AI applications across various industries.

Arm Holdings

Arm Holdings provides critical chip technology that supports many modern devices, enhancing Nvidia's AI capabilities.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 3month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 3month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 3month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 3month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics